0,929  0,005  Apoptosis agonist
0,897  0,003  Chemopreventive
0,898  0,006  Transcription factor NF kappa B inhibitor
0,866  0,008  Antiinflammatory
0,845  0,004  Lipoprotein disorders treatment
0,842  0,005  Atherosclerosis treatment
0,831  0,004  Caspase 3 stimulant
0,830  0,004  Cholesterol antagonist
0,820  0,004  Antineoplastic (liver cancer)
0,805  0,006  Antihypercholesterolemic
0,794  0,005  Bone diseases treatment
0,791  0,010  Antineoplastic (breast cancer)
0,785  0,011  CYP3A4 substrate
0,776  0,005  Antiprotozoal
0,748  0,005  Antiosteoporotic
0,747  0,005  Antiprotozoal (Plasmodium)
0,705  0,005  Antipsoriatic
0,626  0,005  Hypolipemic
0,638  0,025  Antineoplastic (lung cancer)
0,604  0,011  Immunomodulator
0,602  0,017  Carcinogenic
0,587  0,010  Nitric oxide antagonist
0,585  0,012  NOS3 expression inhibitor
0,596  0,025  Antileukemic
0,568  0,002  Liver X receptor alpha agonist
0,551  0,004  Antiparkinsonian, rigidity relieving
0,548  0,003  DNA polymerase I inhibitor
0,550  0,012  Antiprotozoal (Leishmania)
0,554  0,020  Immunosuppressant
0,534  0,017  Proliferative diseases treatment
0,531  0,017  Antioxidant
0,517  0,019  Antifungal
0,512  0,020  Hepatic disorders treatment
0,499  0,008  Hair growth stimulant
0,494  0,006  Contraceptive
0,516  0,028  Antipruritic, allergic
0,487  0,004  Sodium/bile acid cotransporter inhibitor
0,485  0,007  Interferon gamma antagonist
0,496  0,025  Cytotoxic
0,483  0,022  Antineoplastic (brain cancer)
0,459  0,018  UGT2B4 substrate
0,446  0,005  Lipocortins synthesis antagonist
0,447  0,008  Prostate disorders treatment
0,471  0,037  Prostate cancer treatment
0,435  0,006  Antipruritic, non-allergic
0,433  0,011  Abortion inducer
0,471  0,049  Antibacterial
0,458  0,037  Teratogen
0,429  0,009  UGT2B7 substrate
0,423  0,009  Antiacne
0,425  0,019  Antineoplastic (renal cancer)
0,458  0,058  TNF expression inhibitor
0,429  0,038  Antineoplastic (ovarian cancer)
0,385  0,004  Inducible nitric-oxide synthase inhibitor
0,384  0,013  Prostatic (benign) hyperplasia treatment
0,362  0,006  Cholesterol synthesis inhibitor
0,392  0,043  Embryotoxic
0,355  0,009  Diabetic nephropathy treatment
0,377  0,045  Apoptosis antagonist
0,414  0,083  Antidiabetic
0,414  0,083  Cyclophilin D inhibitor
0,426  0,096  Caspase 9 stimulant
0,351  0,022  UGT1A4 substrate
0,372  0,045  Antineoplastic (pancreatic cancer)
0,328  0,005  Antifungal (Cryptococcus)
0,319  0,005  Farnesoid X receptor antagonist
0,342  0,034  Antiparasitic
0,350  0,043  NOS2 expression inhibitor
0,313  0,007  Neurotrophic factor
0,336  0,030  Antihypertriglyceridemic
0,359  0,056  Antihypertensive
0,334  0,042  Antineoplastic (lymphoma)
0,317  0,028  UGT1A1 substrate
0,289  0,004  Liver X receptor agonist
0,325  0,040  Angiogenesis stimulant
0,311  0,033  UDP-glucuronosyltransferase substrate
0,304  0,028  Hepatoprotectant
0,296  0,023  Diuretic
0,270  0,004  Pregnane X receptor agonist
0,277  0,014  UGT2B9 substrate
0,333  0,070  ICAM1 expression inhibitor
0,300  0,044  UGT1A6 substrate
0,311  0,055  Antineoplastic (glioma)
0,266  0,013  Antineoplastic antibiotic
0,324  0,072  Immunostimulant
0,269  0,019  Interleukin 6 antagonist
0,257  0,009  Androgen antagonist
0,253  0,005  Postmenopausal disorders treatment
0,318  0,072  AR expression inhibitor
0,252  0,007  HDL-cholesterol increasing
0,268  0,026  Anesthetic
0,309  0,068  Interleukin 2 agonist
0,279  0,039  Anesthetic general
0,242  0,004  Hypercalcemia treatment
0,291  0,056  Platelet antagonist
0,298  0,073  CTGF expression inhibitor
0,264  0,040  Antihelmintic
0,233  0,010  Arachidonic acid antagonist
0,273  0,055  Antineoplastic (glioblastoma multiforme)
0,217  0,004  Hyperparathyroidism treatment
0,285  0,076  Antineoplastic (melanoma)
0,233  0,030  Antiviral (Influenza A)
0,213  0,014  UGT2B1 substrate
0,212  0,019  Interleukin 4 antagonist
0,279  0,087  Respiratory analeptic
0,264  0,074  Amyotrophic lateral sclerosis treatment
0,254  0,066  Sensitization
0,237  0,052  Antiviral (Influenza)
0,196  0,021  Microtubule formation inhibitor
0,246  0,077  Antidiabetic symptomatic
0,195  0,028  Antihyperlipoproteinemic
0,201  0,036  UGT2B10 substrate
0,154  0,003  Vitamin D receptor antagonist
0,172  0,024  Alcohol dehydrogenase substrate
0,173  0,026  Antischistosomal
0,181  0,034  Protein-tyrosine phosphatase 1B inhibitor
0,158  0,012  UGT2B11 substrate
0,159  0,019  Nitric-oxide synthase inhibitor
0,150  0,013  CDC25A inhibitor
0,143  0,007  Anticholelithogenic
0,176  0,040  Skin irritative effect
0,230  0,095  Interleukin agonist
0,190  0,057  UGT1A3 substrate
0,159  0,028  Contraceptive female
0,136  0,009  Na+ K+ transporting ATPase inhibitor
0,160  0,036  Liver cirrhosis treatment
0,236  0,114  Analeptic
0,234  0,112  Antineoplastic (colorectal cancer)
0,140  0,021  Antibiotic
0,119  0,003  Parathyroid hormone antagonist
0,140  0,024  Interleukin 2 antagonist
0,131  0,016  Antiprotozoal activity enhancer
0,223  0,109  Chemoprotective
0,222  0,109  Antineoplastic (colon cancer)
0,142  0,031  Antiinfertility, female
0,205  0,094  Free radical scavenger
0,133  0,023  Paget's disease treatment
0,192  0,085  Neurotrophic factor enhancer
0,116  0,009  5-Alpha-reductase inhibitor
0,113  0,010  Acetyl-CoA transferase inhibitor
0,156  0,054  Bone formation stimulant
0,131  0,030  Anabolic
0,136  0,037  Anticataract
0,114  0,015  Glycine receptor agonist
0,170  0,074  Toxic, respiratory center
0,162  0,068  Protein-tyrosine phosphatase inhibitor
0,195  0,105  Antineoplastic (cervical cancer)
0,148  0,060  Antifungal enhancer
0,154  0,067  Antidiarrheal
0,086  0,002  Vitamin D receptor agonist
0,084  0,003  HMG CoA reductase inhibitor
0,128  0,047  Choleretic
0,139  0,062  Skin whitener
0,093  0,018  Androgen agonist
0,201  0,126  UGT1A9 substrate
0,157  0,086  Liver fibrosis treatment
0,279  0,208  Antineoplastic (solid tumors)
0,082  0,011  Mineralocorticoid receptor antagonist
0,075  0,005  Acetyl-CoA transferase 1 inhibitor
0,075  0,009  RNA-directed RNA polymerase stimulant
0,107  0,041  SULT1E1 substrate
0,095  0,029  SULT1A2 substrate
0,079  0,014  Lipocortins synthesis agonist
0,105  0,044  ABCA1 expression enhancer
0,102  0,044  Bile acid receptor antagonist
0,091  0,036  T cell inhibitor
0,194  0,141  Renal disease treatment
0,153  0,100  Phospholipase C inhibitor
0,093  0,042  Vanilloid agonist
0,098  0,048  Actinic keratosis treatment
0,118  0,071  Growth stimulant
0,050  0,005  CYP24 inhibitor
0,046  0,004  Hedgehog signaling activator
0,102  0,061  Sulfotransferase substrate
0,058  0,018  Microtubule stabilization
0,051  0,011  Glucose-6-phosphate dehydrogenase inhibitor
0,052  0,014  Farnesoid X receptor agonist
0,049  0,011  Cholesterol absorption inhibitor
0,126  0,089  UGT2B15 substrate
0,131  0,096  Antiviral (Herpes)
0,079  0,044  Antitreponemal
0,136  0,104  Melanin inhibitor
0,184  0,154  Antidiabetic (type 2)
0,146  0,121  Interleukin antagonist
0,129  0,105  Adenylate cyclase stimulant
0,117  0,096  Protein kinase stimulant
0,031  0,012  1,3-Beta-glucan synthase inhibitor
0,027  0,008  Progesterone agonist
0,026  0,010  5-Alpha-reductase 2 inhibitor
0,039  0,023  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,016  0,001  Vitamin D-like
0,015  0,005  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,020  0,012  Apical sodium codependent bile acid transporter inhibitor
0,111  0,104  Lipid peroxidase inhibitor
0,173  0,167  CYP2C19 substrate
0,182  0,177  Metabolic disease treatment
0,020  0,017  Corticosteroid-like
0,136  0,133  LDLR expression enhancer
0,018  0,015  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,016  0,014  Telomerase stimulant
0,015  0,014  Ileal bile acid transport inhibitor
0,092  0,092  SULT1A1 substrate

